These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1706010)

  • 21. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the tolerance and effectiveness of Diltiazem LP 300 mg in hypertensive patients with chronic renal insufficiency].
    Bernadet-Monrozies P; Poilleux E; Suc JM
    Ann Cardiol Angeiol (Paris); 1998 Oct; 47(8):589-94. PubMed ID: 9809145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased vascular compliance/decreased cardiovascular risk: what the studies tell us.
    Frishman WH
    Heart Dis; 2000; 2(5):384-8. PubMed ID: 11728287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the efficacy and tolerability of enalapril and sustained-release diltiazem in mild to moderate essential hypertension.
    Weir MR; Haynie R; Vertes V; Pinson R; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1990; 12(6):473-81. PubMed ID: 2289216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diltiazem-induced left ventricular mass regression in hypertensive patients.
    Weiss RJ; Bent B
    J Clin Hypertens; 1987 Jun; 3(2):135-43. PubMed ID: 2956372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Demographic characteristics and response to antihypertensive treatment. Study using fixed doses of diltiazem].
    Elkik F; Claudel S; Carcone B; Grippon P
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1299-302. PubMed ID: 2510664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diltiazem compared with metoprolol as add-on-therapies to diuretics in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
    Thulin T; Hedner T; Gustafsson S; Olsson SO
    J Hum Hypertens; 1991 Apr; 5(2):107-14. PubMed ID: 2072368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Delayed-action calcium antagonists and therapy of arterial hypertension].
    da Costa JN
    Rev Port Cardiol; 1992; 11(7-8):617-21. PubMed ID: 1389299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy of force titrated doses of diltiazem extended-release. A placebo controlled study.
    Lacourcière Y; Poirier L; Lefebvre J; Burford RG
    Am J Hypertens; 1995 Mar; 8(3):282-6. PubMed ID: 7794578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
    Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
    Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diltiazem in the treatment of hypertension and ischemic heart disease.
    Barrios V
    Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1375-82. PubMed ID: 22059786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy and safety of sustained-release diltiazem in the treatment of hypertension.
    Myburgh DP
    S Afr Med J; 1990 Oct; 78(8):456-7. PubMed ID: 2218780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental and clinical experience with the calcium antagonist diltiazem in hypertension.
    Kiowski W; Linder L; Bühler FR
    J Cardiovasc Pharmacol; 1989; 13 Suppl 1():S25-8. PubMed ID: 2468973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of cardiovascular risk and arterial hypertension. Introduction.
    Safar ME
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():v-vi. PubMed ID: 1706006
    [No Abstract]   [Full Text] [Related]  

  • 40. Long acting diltiazem tablets.
    Drug Ther Bull; 1992 Mar; 30(5):20. PubMed ID: 1591991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.